Close

Animal Biotechnology Policy Committee

Chair: Ronald Stotish, Chief Executive Officer, Aqua Bounty Technologies, Inc.       
Vice Chair: Robin Readnour, Senior Director, Technology Acquisition & Biological Product Development, Elanco, Inc.
Staff Contact: Cathleen Enright, Executive Vice President, Food & Agriculture, cenright(at)bio.org.   

Description: The committee is responsible for strategic planning and work plan objectives, oversight of work plan implementation, and policy position recommendations on animal-based product issues. Membership is composed of companies that enhance livestock production through animal genomics, animal cloning, and transgenics.  Other areas include development of diagnostics, vaccines and animal-made pharmaceuticals to improve animal and human health.

Members: 
Alan Blake, Chief Executive Officer, Yorktown Technologies, LP
Alanna Temme, Director, Federal Government Affairs, Boehringer Ingelheim, Inc.
David Faber, President, Trans Ova Genetics, Inc.
David Ayares, EVP & Head of US Operations, CSO, Revivicor, Inc.
Eddie Sullivan, President & CEO, SAB Biotherapeutics, Inc.
John Swart, President & CEO, Exemplar Genetics, LLC
Richard Scotland, Senior Vice President, Regulatory Affairs, rEVO Biologics, Inc.
Scott Fahrenkrug, CEO & Chairman, Recombinetics, Inc.